Theravance Biopharma (TBPH) EBIT (2013 - 2026)
Theravance Biopharma's EBIT was -$8.28 million in Q2 2026, compared with -$2.73 million a year earlier.
Powered by 
Analysis
Theravance Biopharma (TBPH) EBIT (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Theravance Biopharma's EBIT was -$4.2 million through Jun 30, 2026; for FY2025, it was -$3.6 million.
- In earlier years, EBIT was -$46.95 million in FY2024, -$56.04 million in FY2023, -$91.96 million in FY2022 and -$257.78 million in FY2021.
- Quarterly EBIT has moved between -$56.17 million (Q4 2021) and $20.01 million (Q4 2025) over five years.
- Per Business Quant data, TBPH's EBIT in the three quarters before Q2 2026 was -$9.48 million (Q1 2026), $20.01 million (Q4 2025) and -$6.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.67 Bn | 1,100.26 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 614.28 Bn | 532.81 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.23 Bn | 476.34 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 368.28 Bn | 322.66 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.22 Bn | 262.21 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.55 Bn | 235.23 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 235.92 Bn | 191.31 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.98 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | -8.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.28 Mn |
| Mar 31, 2026 | -9.48 Mn |
| Dec 31, 2025 | 20.01 Mn |
| Sep 30, 2025 | -6.46 Mn |
| Jun 30, 2025 | -2.73 Mn |
| Mar 31, 2025 | -14.43 Mn |
| Dec 31, 2024 | -9.20 Mn |
| Sep 30, 2024 | -10.84 Mn |
| Jun 30, 2024 | -15.71 Mn |
| Mar 31, 2024 | -11.21 Mn |
| Dec 31, 2023 | -6.24 Mn |
| Sep 30, 2023 | -8.76 Mn |
| Jun 30, 2023 | -16.12 Mn |
| Mar 31, 2023 | -24.91 Mn |
| Dec 31, 2022 | -17.43 Mn |
| Sep 30, 2022 | -9.14 Mn |
| Jun 30, 2022 | -26.88 Mn |
| Mar 31, 2022 | -38.50 Mn |
| Dec 31, 2021 | -56.17 Mn |
| Sep 30, 2021 | -53.62 Mn |
API Access
Theravance Biopharma EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();